Shares of Medidata Solutions Inc. (NASDAQ:MDSO) fell 4.1% during trading on Thursday . The stock traded as low as $51.33 and last traded at $51.38, with a volume of 549,523 shares. The stock had previously closed at $53.58.

Several brokerages recently commented on MDSO. Wells Fargo & Co. lowered Medidata Solutions from an “outperform” rating to a “market perform” rating in a report on Thursday. KeyCorp reiterated a “buy” rating and set a $55.00 target price on shares of Medidata Solutions in a research report on Sunday, May 22nd. Jefferies Group downgraded Medidata Solutions from a “hold” rating to an “underperform” rating and lifted their target price for the company from $35.00 to $36.00 in a research report on Tuesday, April 26th. Leerink Swann assumed coverage on Medidata Solutions in a research report on Tuesday, April 26th. They set a “market perform” rating and a $47.00 target price on the stock. Finally, Topeka Capital Markets reiterated a “buy” rating and set a $44.00 target price (up from $42.00) on shares of Medidata Solutions in a research report on Tuesday, April 5th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $51.20.

The firm has a market capitalization of $2.82 billion and a PE ratio of 156.44. The company’s 50 day moving average is $46.70 and its 200 day moving average is $41.92.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings results on Wednesday, July 20th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.23 by $0.01. During the same quarter in the prior year, the business earned $0.22 EPS. The firm had revenue of $114.60 million for the quarter, compared to analyst estimates of $112.39 million. The firm’s quarterly revenue was up 16.8% on a year-over-year basis. Equities research analysts expect that Medidata Solutions Inc. will post $1.02 earnings per share for the current year.

In related news, EVP Eileen Schloss sold 68,717 shares of Medidata Solutions stock in a transaction that occurred on Monday, April 25th. The shares were sold at an average price of $46.53, for a total value of $3,197,402.01. Following the completion of the sale, the executive vice president now owns 22,361 shares in the company, valued at approximately $1,040,457.33. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Vries Glen Michael De sold 7,500 shares of Medidata Solutions stock in a transaction that occurred on Monday, April 25th. The shares were sold at an average price of $46.36, for a total transaction of $347,700.00. Following the completion of the sale, the president now owns 1,086,425 shares of the company’s stock, valued at approximately $50,366,663. The disclosure for this sale can be found here.

Other hedge funds recently bought and sold shares of the company. State of Tennessee Treasury Department bought a new stake in Medidata Solutions during the fourth quarter valued at $2,124,000. Sawtooth Asset Management Inc. increased its stake in Medidata Solutions by 7,730.8% in the fourth quarter. Sawtooth Asset Management Inc. now owns 20,360 shares of the company’s stock valued at $1,004,000 after buying an additional 20,100 shares during the period. Century Capital Management LLC increased its stake in Medidata Solutions by 18.8% in the fourth quarter. Century Capital Management LLC now owns 126,397 shares of the company’s stock valued at $6,230,000 after buying an additional 20,027 shares during the period. Bank of Montreal Can increased its stake in Medidata Solutions by 96.6% in the fourth quarter. Bank of Montreal Can now owns 33,760 shares of the company’s stock valued at $1,664,000 after buying an additional 16,587 shares during the period. Finally, Principal Financial Group Inc. increased its stake in Medidata Solutions by 3.5% in the fourth quarter. Principal Financial Group Inc. now owns 372,108 shares of the company’s stock valued at $18,341,000 after buying an additional 12,610 shares during the period.

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.